A phase I scientific exploratory study of epothilone B analog (BMS-247550; NSC 710428) [ixabepilone] in patients with [advanced or recurrent] solid tumors and gynecological malignancies

Trial Profile

A phase I scientific exploratory study of epothilone B analog (BMS-247550; NSC 710428) [ixabepilone] in patients with [advanced or recurrent] solid tumors and gynecological malignancies

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Feb 2017

At a glance

  • Drugs Ixabepilone (Primary)
  • Indications Advanced breast cancer; Ovarian cancer; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 11 Jan 2007 Status change
    • 17 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top